Introduction/Overview
Hydroxyl - γ - isosanshook (CAS number 127514-62-9) is a class of compounds found in cloves(Syzygium aromaticum)And Seven Leaf Grass(Hydrocotyle Natural alkylamide compounds found in plants such as spp. As one of the main active ingredients in these plants, hydroxyl - γ - isocoumarin has attracted much attention due to its unique chemical structure and significant biological activity. One of its most significant physiological effects is the induction of local numbness, which makes it of great significance in both traditional medicine and modern pharmacological research. In recent years, with the in-depth analysis of the pharmacological mechanisms of natural products, the potential application value of hydroxyl - γ - isocoumarin in anti-inflammatory, analgesic and other fields has gradually emerged, becoming a hot topic in natural product pharmacology research.
This review aims to systematically summarize the chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activity and mechanism of action, pharmacological evaluation and pharmacokinetic characteristics of hydroxy - γ - isocoumarin, and explore its clinical application prospects and development directions in combination with its target effects in anti-inflammatory related diseases, providing comprehensive references for researchers in related fields.
Chemical structure and physicochemical properties
Hydroxyl - γ - isocoumarin belongs to the alkyl amide class of natural products, with a molecular formula of C18H27NO2 and a molecular weight of 289.4190. Its chemical structural features include a long-chain fatty amide skeleton and a hydroxyl modified gamma isocoumarin core structure, endowing it with unique biological activity. The LogP value of this compound is 3.0072, indicating moderate lipid solubility that facilitates membrane penetration and in vivo distribution. The polar surface area (TPSA) is 49.33 Å ², indicating that the molecule has certain polar groups that facilitate binding to biomolecule targets.
The low water solubility (0.0363 mg/mL) indicates that the solubility of hydroxyl - γ - isocoumarin in the aqueous phase is limited, which may affect its bioavailability. It is worth noting that this compound has a high ability to penetrate the blood-brain barrier, suggesting its potential role in the central nervous system. The negative result of hERG channel inhibition experiment indicates a low risk of cardiac toxicity. The Ames mutagenicity test result was 0.0, indicating that hydroxy - γ - isocoumarin has no significant genetic toxicity and good safety.
Plant sources and extraction methods
Hydroxy - γ - isocoumarin is mainly present in the volatile oils and lipid soluble extracts of cloves and seven leaf clover. Lilac, as a spice plant widely used in food seasoning and traditional medicine, contains abundant volatile components and alkyl amide compounds in its flower buds. Seven leaf clover has been widely studied for its diverse medicinal values, and its oil components also contain hydroxyl - γ - isocoumarin.
The extraction method usually uses solvent extraction combined with chromatographic separation technology. Commonly used solvents include ethanol, ethyl acetate, and n-hexane. Based on their lipophilicity characteristics, suitable polar solvents are selected to improve extraction efficiency. The extraction process generally includes crushing plant materials, solvent soaking, ultrasound assisted extraction or reflux extraction, and then obtaining crude extract through rotary evaporation concentration. The purification steps mainly rely on column chromatography (such as silica gel column, reverse phase C18 column) and high performance liquid chromatography (HPLC) to obtain high-purity hydroxyl - γ - isocoumarin.
In recent years, supercritical CO2 extraction technology has gradually been applied to the extraction of such components due to its green environmental protection and high selectivity, significantly improving the extraction purity and yield, and avoiding the problem of residual organic solvents.
Pharmacological activity research
The pharmacological activities of hydroxy - γ - isocapsaicin mainly focus on anti-inflammatory, analgesic, and neuromodulatory aspects. Its most well-known physiological effect is the induction of local numbness, which is closely related to its regulation of specific ion channels.
anti-inflammatory activity
A large number of in vitro and in vivo experiments have shown that hydroxyl - γ - isocapsaicin has significant anti-inflammatory effects. It reduces inflammation by inhibiting the release and expression of various inflammatory mediators. Specifically, it manifests as reducing the levels of pro-inflammatory cytokines such as IL-6 and TNF - α, inhibiting the activity of inflammation related enzymes such as PTGS1 (COX-1), PTGS2 (COX-2), and NOS2 (inducible nitric oxide synthase), thereby reducing tissue inflammatory damage.
Analgesic effect
Hydroxy - γ - isocoumarin has a regulatory effect on pain receptors such as TRPV1 and TRPA1. TRPV1 (capsaicin receptor) and TRPA1 (aromatic hydrocarbon receptor) are important ion channels in sensory nerves involved in the transmission of pain and inflammatory signals. Hydroxyl - γ - isocapsaicin exhibits analgesic effects by regulating the activity of these channels, inhibiting the transmission of pain signals.
Neuromodulation
The compound has a high blood-brain barrier penetration ability, suggesting its possible involvement in the regulation of the central nervous system. Research has shown that hydroxy - γ - isocoumarin has regulatory effects on transcription factors such as STAT3 and NFKB1, which play key roles in neuroinflammation and neuroprotection, suggesting its potential application value in neurological diseases.
Mechanism of action and molecular targets
The pharmacological mechanism of hydroxyl - γ - isocapsaicin involves multiple signaling pathways and molecular targets, mainly focusing on inflammation regulation and neural receptor regulation.
Inflammatory related targets
- IL-6 (interleukin-6)Hydroxyl - γ - isocapsaicin can inhibit the expression of IL-6 and alleviate inflammatory response. IL-6 is a key mediator of various inflammatory and immune responses, and its overexpression is closely related to various chronic inflammatory diseases.
- STAT3 (Signal Transduction and Transcription Activation Factor 3)As a downstream transcription factor of the IL-6 signaling pathway, STAT3 regulates the expression of inflammatory genes. Hydroxyl - γ - isocapsaicin inhibits the activation of STAT3 and blocks inflammatory signaling.
- CASP1 (caspase 1)CASP1 is involved in the maturation and release of pro-inflammatory cytokine IL-1 β. The inhibitory effect of hydroxyl - γ - isocapsaicin on CASP1 helps alleviate the inflammatory cascade reaction.
- PTGS1 and PTGS2 (cyclooxygenase 1 and 2)Hydroxyl - γ - isocapsaicin inhibits the activity of these two enzymes, reduces the production of prostaglandins, and lowers inflammation and pain.
- TNF (tumor necrosis factor alpha)Hydroxyl - γ - isocapsaicin can inhibit the expression of TNF - α and alleviate inflammatory response.
- NOS2 (inducible nitric oxide synthase)By inhibiting NOS2 and reducing the production of excessive nitric oxide, oxidative stress and inflammatory damage can be prevented.
- NFKB1 (nuclear factor kappa B subunit 1)Hydroxyl - γ - isocapsaicin blocks the NFKB signaling pathway, inhibits the transcription of pro-inflammatory genes, and exerts anti-inflammatory effects.
Neurosensory targets
- TRPV1 (Transient receptor potential vanillic acid receptor 1)Hydroxyl - γ - isocapsaicin regulates TRPV1 channel activity, affects calcium ion influx, and regulates pain and numbness.
- TRPA1 (Transient receptor potential vanillic acid receptor related channel 1)By regulating TRPA1, hydroxyl - γ - isocapsaicin participates in the regulation of chemical pain and inflammation perception.
In summary, hydroxyl - γ - isocapsaicin exerts its pharmacological effects of anti-inflammatory and analgesic through multi-target and multi pathway synergistic effects.
Evaluation of drug properties and pharmacokinetics
The pharmacological analysis of hydroxyl - γ - isocoumarin shows that it has good potential for drug development. The molecular weight of 289.4190 conforms to Lipinski's rule, and the LogP value of 3.0072 indicates moderate lipid solubility, which is beneficial for oral absorption and cell membrane penetration. The TPSA is 49.33 Å ², which supports its good biofilm permeability.
Low water solubility may limit its oral bioavailability, but it can be improved through formulation techniques such as nanocarriers and liposome encapsulation. Its high blood-brain barrier penetration ability provides the possibility for the treatment of central nervous system diseases.
In terms of safety, the hERG channel has no inhibitory effect and reduces the risk of cardiac toxicity; The Ames test is negative, indicating no mutagenicity and good safety.
Pharmacokinetic studies are still in the preliminary stage, and existing literature reports that hydroxy - γ - isocoumarin has good distribution characteristics in vivo. The metabolic pathways mainly involve the liver enzyme system, and the metabolites need further identification. The parameters such as half-life and clearance rate are yet to be systematically studied.
Clinical application prospects and prospects
Hydroxy - γ - isocapsaicin, as a natural anti-inflammatory and analgesic active ingredient, has broad clinical application potential. Its multi-target mechanism of action makes it of great value in the treatment of chronic inflammatory diseases (such as rheumatoid arthritis, inflammatory bowel disease), neuropathic pain, and neuroinflammatory diseases.
Future research should focus on:
- Pharmacokinetic and Toxicological Systematic Review Clarify its metabolic pathways, pharmacokinetic characteristics, and long-term safety.
- Formulation optimization To solve the problem of poor water solubility, improve bioavailability, and develop formulations suitable for clinical applications.
- Preclinical model validation Using animal models of inflammation and pain, further validate its efficacy and mechanism of action.
- Clinical trial design Conduct early clinical studies to evaluate its safety, tolerability, and initial efficacy.
- Structural modification and derivative development Design derivatives with higher activity and better pharmacokinetic properties based on the hydroxyl - γ - isocoumarin structure.
In addition, given its regulatory effects on TRPV1 and TRPA1 channels, the potential of hydroxy - γ - isocapsaicin in the field of neural regulation is also worth exploring, especially in the treatment of chronic pain and neurodegenerative diseases.
Conclusion
Hydroxy - γ - isocoumarin, as an important alkyl amide natural product in clove and seven leaf clover oil, has shown great potential as a drug due to its unique chemical structure and significant anti-inflammatory and analgesic activities. Its multi-target and multi mechanism mode of action provides valuable examples for the pharmacological research of natural products. In the future, with the deepening of pharmacokinetics, toxicology, and clinical research, hydroxy - γ - isocoumarin is expected to become an important candidate molecule for the development of natural product drugs, promoting innovation and application of natural anti-inflammatory drugs.
This review systematically summarizes the research progress of hydroxy - γ - isocoumarin, aiming to provide theoretical basis and reference for scientific research and drug development in related fields, and promote its translational application in clinical treatment.